Used primarily in research settings as a selective inhibitor of fatty acid amide hydrolase (FAAH), this compound plays a role in studying endocannabinoid signaling pathways. By inhibiting FAAH, it increases levels of endogenous cannabinoids like anandamide, making it valuable in investigating pain modulation, inflammation, and neurological disorders such as anxiety and depression. It serves as a tool compound in preclinical studies to explore the therapeutic potential of modulating the endocannabinoid system without directly activating cannabinoid receptors. Its structure allows for good blood-brain barrier penetration, enhancing its utility in central nervous system research.